Reckitt unveils new solution
image for illustrative purpose
Hyderabad: Reckitt, a global consumer health, hygiene, and nutrition company under its brand Gaviscon, launched Gaviscon Double Action in Telangana. The product is a solution to symptomatic reflux.
The company pointed out that in India, the prevalence of GERD (gastroesophageal reflux disease) ranges from 7.6 per cent to 30 per cent, with most cases below 10 per cent. Reflux is the backward movement of acid or stomach contents back into the food pipe, and it causes symptoms such as burning in chest, stomach discomfort sour taste and bad breath.
Commenting on the launch, Edward Thomas, Global Medical Marketing Manager, GI and Manav Sohal, Brand Manager, Reckitt India (Strepsils and Gaviscon) said, “We have built a good reputation in the market based on high-quality Gaviscon products that have been prescribed by doctors globally for over 40 years now. Gaviscon Double Action is our latest addition in the range of solutions that we have introduced to India. The launch symposia held today is going to be invaluable in terms of knowledge dissemination related to the problem of reflux and on improving patient care in India.”